CJC 1295 Ipamorelin Side Effects: Research
Item added to your cart
When a user selects CJC‑1295 or Ipamorelin for purchase, the system registers the item in the shopping cart. The cart displays the product name, dosage, quantity, and total price. Users can adjust quantities, remove items, or proceed to checkout. A confirmation message confirms that the item has been added successfully.
CJC 1295 Ipamorelin Side Effects: Research
Both CJC‑1295 (a growth hormone releasing peptide) and Ipamorelin (a selective ghrelin receptor agonist) are studied for their potential to stimulate growth hormone release. Clinical trials and anecdotal reports indicate several side effects:
Injection site reactions – redness, swelling, or itching at the injection point.
Water retention and edema – mild puffiness of hands, feet, or face due to fluid accumulation.
Headaches – tension‑type headaches reported by some users during initial dosing periods.
Nausea or gastrointestinal discomfort – transient stomach upset in a minority of participants.
Increased appetite – particularly with Ipamorelin, which mimics ghrelin’s hunger signaling.
Potential hormonal imbalances – long‑term use may affect cortisol, insulin, and thyroid hormones; monitoring is advised.
Research highlights that most side effects are mild to moderate and often diminish as the body adapts. However, rare reports of joint pain or dizziness suggest a need for cautious dosage escalation and regular medical oversight.
Subscribe to our emails
Stay updated with the latest research findings, product releases, and expert insights by subscribing to our email newsletter. Enter your email address below and receive timely updates directly in your inbox.
